MOTESANIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H23N5O
Molecular Weight	373.4509
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of MOTESANIB

Structure Search

SMILES

CC1(C)CNC2=C1C=CC(NC(=O)C3=CC=CN=C3NCC4=CC=NC=C4)=C2

InChI

InChIKey=RAHBGWKEPAQNFF-UHFFFAOYSA-N

InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)

HIDE SMILES / InChI

Molecular Formula	C22H23N5O
Molecular Weight	373.4509
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:23:00 UTC 2023` Edited by `admin` on `Fri Dec 15 17:23:00 UTC 2023`
Record UNII	U1JK633AYI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MOTESANIB

Official Name

English

AMG-706

Code

English

N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide

Systematic Name

English

N-(3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-6-YL)-2-((PYRIDIN-4-YLMETHYL)AMINO)NICOTINAMIDE

Systematic Name

English

MOTESANIB [USAN]

Common Name

English

3-PYRIDINECARBOXAMIDE, N-(2,3-DIHYDRO-3,3-DIMETHYL-1H-INDOL-6-YL)-2-((4-PYRIDINYLMETHYL)AMINO)-

Systematic Name

English

AMG 706

Code

English

MOTESANIB [MART.]

Common Name

English

motesanib [INN]

Common Name

English

Motesanib [WHO-DD]

Common Name

English

MOTESANIB [MI]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C1967

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

Code System Code Type Description

CAS

453562-69-1

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

EPA CompTox

DTXSID10196488

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

MERCK INDEX

m7636

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

Merck Index

ChEMBL

CHEMBL572881

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

NCI_THESAURUS

C71896

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

SMS_ID

100000141571

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

INN

8828

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

WIKIPEDIA

MOTESANIB

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

USAN

SS-13

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

DRUG BANK

DB05575

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

EVMPD

SUB93453

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

FDA UNII

U1JK633AYI

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

PUBCHEM

11667893

Created by admin on Fri Dec 15 17:23:00 UTC 2023 , Edited by admin on Fri Dec 15 17:23:00 UTC 2023

PRIMARY

Related Record Type Details


					2Z7LDE78YX

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> INHIBITOR

Amount:


					T6Q3060U91

MOTESANIB DIPHOSPHATE

SALT/SOLVATE -> PARENT


					798536Z7S0

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2

TARGET -> INHIBITOR


					0RFO7VC96N

URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A1

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR


					6G09NND37S

VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1

TARGET -> INHIBITOR


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Related Record Type Details


					J7ZNA4QT6F

3-PYRIDINECARBOXAMIDE, 2-AMINO-N-(2,3-DIHYDRO-3,3-DIMETHYL-2-OXO-1H-INDOL-6-YL)-

METABOLITE -> PARENT


					3MC5QZQ8UN

3-PYRIDINECARBOXAMIDE, N-(2,3-DIHYDRO-3,3-DIMETHYL-2-OXO-1H-INDOL-6-YL)-2-((4-PYRIDINYLMETHYL)AMINO)-

METABOLITE -> PARENT


					1O95S36Q60

.BETA.-D-GLUCOPYRANURONIC ACID, 1-(2,3-DIHYDRO-3,3-DIMETHYL-6-(((2-((4-PYRIDINYLMETHYL)AMINO)-3-PYRIDINYL)CARBONYL)AMINO)-1H-INDOLE-1-CARBOXYLATE)

METABOLITE -> PARENT


					R7F7L74HXU

.BETA.-D-GLUCOPYRANURONIC ACID, 1-DEOXY-1-(2,3-DIHYDRO-3,3-DIMETHYL-6-(((2-((4-PYRIDINYLMETHYL)AMINO)-3-PYRIDINYL)CARBONYL)AMINO)-1H-INDOL-1-YL)-

METABOLITE -> PARENT

Interaction Type:

MAJOR


					QDP9RVA535

3-PYRIDINECARBOXAMIDE, N-(2,3-DIHYDRO-2-HYDROXY-3,3-DIMETHYL-1H-INDOL-6-YL)-2-((4-PYRIDINYLMETHYL)AMINO)-

METABOLITE -> PARENT


					54WC7W3QYB

3-PYRIDINECARBOXAMIDE, N-(2,3-DIHYDRO-3,3-DIMETHYL-1H-INDOL-6-YL)-2-(((1-OXIDO-4-PYRIDINYL)METHYL)AMINO)-

METABOLITE -> PARENT

Related Record Type Details


					U1JK633AYI

MOTESANIB

ACTIVE MOIETY